Frumovitz M, Westin SN, Salvo G, Zarifa A, et al. Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol Oncol 2020;158:570-575.
PMID: 32534809